Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

GSK 1,464.50 +14.00 (0.97%)
price chart
GlaxoSmithKline pay $3b fine after pleading guilty to healthcare fraud
Carmen Ortiz, the US attorney for Massachusetts, said: 'GSK's sales force bribed physicians to prescribe GSK products using every imaginable form of high priced entertainment, from Hawaiian vacations to paying doctors millions of dollars to go on ...
Glaxo Agrees to Pay $3 Billion in Fraud Settlement  New York Times
GlaxoSmithKline pays US$3-billion to settle biggest healthcare fraud case in ...  Financial Post (blog)
Glaxo to Pay $3 Billion for Human Genome
July 16 (Bloomberg) -- GlaxoSmithKline Plc agreed to buy Human Genome Sciences Inc. for $3 billion in cash, winning control of its U.S.
GlaxoSmithKline to acquire Human Genome Sciences  Baltimore Sun (blog)
Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
Law360, New York (July 31, 2012, 7:17 PM ET) -- GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co.
Glaxo in $3 Billion Settlement
Drug maker GlaxoSmithKline GSK 0.45 % PLC agreed to plead guilty to criminal charges of illegally marketing drugs and withholding safety data from U.S.
Glaxo Pleads Guilty, Fined $1 Billion in Drug-Marketing Case  Bloomberg
Big Pharma is in big trouble � or should be
Something is definitely wrong in their management and monitoring systems. GSK are not able to say that the activities for which they were fined were anything other than deliberate.
Stocks That Avoid Unrecoverable Foreign Dividend Withholding In Tax Deferred ...
While we cannot be entirely certain, it appears that BHP (the Australian ADR for BHP Billiton plc) is partially franked. However, since the other BHP Billiton plc ADR (BBL) is U.K. based, paying a higher net yield (not subject to dividend tax ...
3 U.K. Stocks With U.S.-Style Dividends And No Tax Withholding For A Dividend ...
GlaxoSmithKline PLC - This is one of the largest pharmaceutical companies in the world, having a market capitalization of $116 billion.
Glaxo Executives Cited in Case Now Lead Sanofi, Actelion
July 4 (Bloomberg) -- Two senior executives at GlaxoSmithKline Plc singled out by the U.S. Justice Department for pushing the Advair asthma drug for unapproved uses have moved on to some of Europe's top pharmaceutical companies.
Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG ...
Human Genome Sciences Inc. (NASDAQ: HGSI) remains in the hopeful biotech merger rumor mill. The company has a low-ball tender offer from GlaxoSmithKline PLC (NYSE: GSK) valuing it at $2.6 billion. Now that the company has opened up its options, ...
SEC filing: GlaxoSmithKline makes clean sweep of Human Genome Sciences ...
Whether Glaxo would keep the local company's management in place was the subject of great speculation after the buyout was announced earlier this month.